Edwards Lifesciences EW
NYSE EW
$91.86 -0.42 (-0.46%)
At close: Aug 20, 2026 · 10:04 AM UTC

Edwards Lifesciences (EW) Interest & Investment Income (2025 - 2026)

Edwards Lifesciences (EW) posted quarterly Interest & Investment Income of $33.5 million for Q1 2026, down 8.22% year-over-year from $36.5 million in Q1 2025, and down 8.22% quarter-over-quarter from $36.5 million in Q1 2025.

Edwards Lifesciences (EW) Interest & Investment Income (2025 - 2026) Analysis & Trends

Edwards Lifesciences' Interest & Investment Income history runs 2 years deep, the most recent figure standing at $33.5 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn 52.00 Mn
2 Stryker 130.69 Bn 127.22 Bn 4.50 Bn -
3 Medtronic 120.89 Bn 111.67 Bn 6.41 Bn -
4 Boston Scientific 75.26 Bn 74.72 Bn 3.85 Bn -
5 Edwards Lifesciences 52.88 Bn 48.63 Bn 1.35 Bn 30.00 Mn
6 Dexcom 34.76 Bn 32.81 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.84 Bn 31.74 Bn 2.18 Bn -
8 Koninklijke Philips 26.47 Bn 23.15 Bn 4.55 Bn 73.23 Mn
9 Steris 23.26 Bn 22.78 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 19.46 Bn 19.05 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 30.00 Mn
Mar 31, 2026 33.50 Mn
Mar 31, 2025 36.50 Mn